Alexander Disease

This is a rare condition that affects the brain. It causes a buildup of special proteins in the brain tissue, leading to problems with movement and coordination. It usually starts in early childhood.

Condition

What people with Alexander Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Zanvastro (Zilganersen) for Alexander Disease?

NameHow it went

About Alexander Disease

What It Is

Alexander disease is a rare genetic disorder of the brain and spinal cord that usually worsens over time. It belongs to the leukodystrophies, a group of conditions that damage white matter, the insulated nerve fibers that carry signals between different parts of the nervous system. When those signals slow or fail, movement, speech, swallowing and, in young children, development are affected. The disease looks quite different depending on when it starts. Most diagnoses are made in infants and young children, who may have delayed or lost milestones, seizures, an unusually large head and stiff limbs. A rare form beginning in the first month of life is the most severe. When the disease starts later in childhood or adulthood, it more often shows up as trouble swallowing, slurred or nasal speech, unsteady walking and leg stiffness, while development and thinking may be little affected. Because these adult symptoms are not specific, the disease can be mistaken for multiple sclerosis or a tumor.

Causes & Risk Factors

Alexander disease is caused by a change (variant) in the gene for glial fibrillary acidic protein (GFAP), a structural protein inside astrocytes, the star-shaped cells that support and nourish nerve cells. The altered protein builds up into clumps called Rosenthal fibers, which disrupt how astrocytes work and, in turn, how white matter is formed and maintained. Exactly how this leads to symptoms is still being worked out. In most people with Alexander disease, the variant is new: it arose by chance and neither parent carries it, so nothing the parents did or did not do caused it. One altered copy of the gene is enough to cause the disease. An adult with a slowly progressing form who carries the variant has a 50% chance of passing it to each child, and familial cases are increasingly recognized in adult-onset disease.

How It's Diagnosed

Diagnosis usually starts with a neurological examination and an MRI (magnetic resonance imaging) scan of the brain and spinal cord. In early-onset disease, MRI often shows a characteristic pattern of white matter changes, especially toward the front of the brain, which points strongly toward Alexander disease. In later-onset disease, white matter may look nearly normal, and the clues are more often changes in the brainstem, cerebellum or upper spinal cord. The diagnosis is confirmed with genetic testing from a blood or cheek-swab sample that finds a disease-causing GFAP variant. A brain biopsy, once used to look for Rosenthal fibers, is rarely needed now. Because other inherited white matter diseases can look similar, testing may also rule those out. In a small share of people with typical features, no GFAP variant is found, so a negative test does not completely exclude the disease. Once a family's variant is known, relatives can be tested, and testing during pregnancy or before embryo implantation is possible.

Treatment Options

Treatment has two parts: care that manages symptoms and protects function, and, since 2026, a medicine aimed at the cause. Supportive care is coordinated by several specialists. Seizure medicines control seizures. Physical and occupational therapy help with stiffness, mobility and daily tasks, and speech therapy helps with communication and swallowing. Nutrition support matters because vomiting, poor weight gain and swallowing problems are common, and the safety of eating by mouth is checked as the disease changes. Children benefit from educational services matched to their needs. Zilganersen (Zanvastro) was approved by the US Food and Drug Administration in 2026 for children and adults with Alexander disease. It is an antisense oligonucleotide, a short strand of genetic material designed to reduce how much GFAP protein the body makes, targeting the buildup behind the disease. It is given every 3 months as an injection into the spinal fluid by lumbar puncture (spinal tap). In the main study, people 5 and older with walking difficulty (adults only if symptoms had begun within the past 5 years) who received it kept their walking speed roughly steady over about 14 months, while walking speed fell by about a third in the comparison group; a small group of children aged 2 to 4 also did better on motor measures. The trial was small, and the medicine is meant to slow decline, not repair damage already done. Common side effects include headache (including headache from the spinal tap), back pain, vomiting and cough. It can also cause aseptic meningitis, an inflammation of the lining around the brain triggered by the medicine rather than by infection.

What to Expect

The course of Alexander disease varies more than its name suggests. The neonatal form progresses quickly and is often fatal within the first two years. Infantile-onset disease may cause steady loss of skills during childhood, or it may advance slowly over decades. Adult-onset disease generally progresses gradually, with swallowing, speech and walking changing over years. In general, the earlier symptoms begin, the faster the decline, though there are exceptions. Daily life is shaped by the symptoms present: managing seizures, mealtimes that take more care, mobility aids, and therapy routines. Seizures in children are often set off by ordinary illnesses such as a fever or stomach bug, so infections deserve attention. Regular follow-up tracks neurological change, growth and nutrition, swallowing safety, breathing and sleep, bladder function and developmental or school needs, so support can be adjusted as things change. For families considering zilganersen, each dose involves a clinic visit for the spinal tap, which may mean travel to a specialist center, plus time to rest and recover afterward. Because the disease is so rare, connecting with a leukodystrophy center and other affected families can be especially valuable, and genetic counseling helps relatives understand their own risk.

When to Seek Help

Arrange a neurological evaluation for a baby or child who is missing or losing milestones, has seizures or a head that is growing unusually fast, or for an adult with progressive swallowing or speech difficulty, unexplained unsteady walking or leg stiffness, especially when MRI findings are unexplained. For someone already diagnosed, contact the care team promptly when seizures become more frequent or appear during an illness, when coughing or choking at meals, repeated vomiting or weight loss suggest eating is no longer safe or adequate, or when there is a noticeable new loss of skills. After a zilganersen dose, contact the treating team about fever, a stiff neck, or headache or vomiting that is worse than usual, since these can signal aseptic meningitis.

Questions to Ask Your Doctor

  1. 1.Which form of Alexander disease does this appear to be, and what does that suggest about how it may progress?
  2. 2.Is zilganersen an option for us, and what would treatment, monitoring and travel for the injections involve?
  3. 3.How should we watch for swallowing problems, and what feeding support might help if eating by mouth becomes unsafe?
  4. 4.What should we do when an illness or fever brings on more seizures, and can we have a written seizure action plan that says when rescue medicine or emergency help is needed?
  5. 5.Should other family members have genetic testing, and what would the results mean for future pregnancies?

Last reviewed • Oct 2026

Educational content, not medical advice.